Understanding IgA Nephropathy: Evolving Insights Into Disease State Pathophysiology as a Foundation for Novel Treatment Options

Did you know that 25 to 30 percent of patients with immunoglobulin A nephropathy (IgAN) will progress to end-stage kidney disease within 20 to 25 years of presentation?

Credit available for this activity expires: 1/10/2024

Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/986542?src=mkm_podcast_addon_986542